APLM vs RLYB

APLM's Piotroski F-Score of 3/9 indicates weak financial health, with significant red flags in profitability, cash flow, and leverage. The company exhibits extreme negative profitability metrics, including a -124.8% operating margin and -380.13% ROE, despite a 380.8% YoY revenue growth. With no Altman Z-Score available and a current ratio of 0.97, liquidity concerns persist. The stock trades at a high Price/Sales of 6.15 and a negative forward P/E of -30.62, suggesting valuation is driven by speculative growth expectations rather than fundamentals. The 52-week price range of $3.66 to $42.12 reflects extreme volatility, and the 5-year return of -98.0% underscores long-term underperformance.

RLYB exhibits critical fundamental weakness, highlighted by a Piotroski F-Score of 0/9, indicating a complete lack of financial health across profitability and efficiency metrics. While the company maintains a strong liquidity position with a Current Ratio of 14.51 and zero debt, its operating margin of -2888.29% and a Price/Sales ratio of 50.68 suggest an unsustainable burn rate and extreme overvaluation relative to current revenue. The recent 1-year price surge appears speculative, as it is decoupled from the deterministic health scores and a bearish technical trend of 0/100.